0001209191-20-062948.txt : 20201211
0001209191-20-062948.hdr.sgml : 20201211
20201211163530
ACCESSION NUMBER: 0001209191-20-062948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MEDEL ROGER MD
CENTRAL INDEX KEY: 0001093125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12111
FILM NUMBER: 201383912
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDNAX, INC.
CENTRAL INDEX KEY: 0000893949
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
IRS NUMBER: 263667538
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
BUSINESS PHONE: 9543840175
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
FORMER COMPANY:
FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC
DATE OF NAME CHANGE: 19950801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-09
0
0000893949
MEDNAX, INC.
MD
0001093125
MEDEL ROGER MD
1301 CONCORD TERRACE
SUNRISE
FL
33323
1
0
0
0
Common Stock
2015-07-20
5
G
0
E
12735
0.00
D
1691877
D
Common Stock
2015-07-24
5
G
0
E
1645
0.00
D
1690232
D
Common Stock
2020-12-09
4
S
0
66806
23.002
D
1623426
D
Common Stock
2020-12-10
4
S
0
33194
23.0439
D
1590232
D
Reflects a gift of 12,735 shares of Common Stock made by the Reporting Person on July 20, 2015 that was not previously reported.
Reflects a gift of 1,645 shares of Common Stock made by the Reporting Person on July 24, 2015 that was not previously reported.
Sales made pursuant to Reporting Person's 10b5-1 trading plan adopted on August 13, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in eight separate transactions with prices ranging from $23.00 to $23.04 for an average weighted sale price of $23.002. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4.
The price reported in Column 4 is a weighted average price. These shares were sold in twenty-seven (27) separate transactions with prices ranging from $23.00 to $23.15 for an average weighted sale price of $23.0439. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5.
/s/ Dominic J. Andreano, Attorney-in-Fact
2020-12-11